TickerFacts.

Anika Therapeutics, Inc. (ANIK): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$25.77M
Year ended 2025-12-31
$27.45M
Trailing 12 months to 2026-06-30
+12.0%
3-year compound annual growth
$27.33M2009-12-31: $8.18M2010-12-31: $6.87M2011-12-31: $6.17M2012-12-31: $5.39M2013-12-31: $7.06M2014-12-31: $8.14M2015-12-31: $8.99M2016-12-31: $10.73M2017-12-31: $18.79M2018-12-31: $18.19M2019-12-31: $16.66M2020-12-31: $23.43M2021-12-31: $27.33M2022-12-31: $18.32M2023-12-31: $21.76M2024-12-31: $25.54M2025-12-31: $25.77M$25.77M
2009-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$25.77M+0.9%2026-03-03, From 2025-01-01
2024-12-31$25.54M+17.4%2026-03-03, From 2024-01-01
2023-12-31$21.76M+18.8%2026-03-03, From 2023-01-01
2022-12-31$18.32Mn/c2025-03-17, From 2022-01-01
2021-12-31$27.33M+16.6%2024-03-15, From 2021-01-01
2020-12-31$23.43M+40.6%2023-03-16, From 2020-01-01
2019-12-31$16.66M-8.4%2022-03-11, From 2019-01-01
2018-12-31$18.19M-3.2%2021-04-26, From 2018-01-01
2017-12-31$18.79M+75.1%2020-03-06, From 2017-01-01
2016-12-31$10.73M+19.4%2019-02-27, From 2016-01-01
2015-12-31$8.99M+10.4%2018-02-27, From 2015-01-01
2014-12-31$8.14M+15.4%2017-02-24, From 2014-01-01
2013-12-31$7.06M+31.0%2016-03-10, From 2013-01-01
2012-12-31$5.39M-12.7%2015-03-13, From 2012-01-01
2011-12-31$6.17M-10.3%2014-03-13, From 2011-01-01
2010-12-31$6.87M-16.0%2013-03-14, From 2010-01-01
2009-12-31$8.18Mn/a2012-03-13, From 2009-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Anika Therapeutics, Inc. (ANIK)2025-12-31$25.77M+0.9%
Orasure Technologies Inc (OSUR)2025-12-31$42.53M+63.3%
Beta Bionics, Inc. (BBNX)2025-12-31$34.79M+32.9%
NeuroPace Inc (NPCE)2025-12-31$27.89M+17.9%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$19.48M+24.5%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$2.10M-11.9%
Pulmonx Corp (LUNG)2025-12-31$19.49M+10.9%
Neuronetics, Inc. (STIM)2025-12-31$6.58M-48.4%
Delcath Systems, Inc. (DCTH)2025-12-31$29.25M+110.8%

Compare ANIK, OSUR, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗